Quantifying the Role of Natalizumab in Health and Economic Outcomes in Multiple SclerosisByDavid W. Brandes, MS, MD, FAAN,Fadia T. Shaya, PhD, MPH,Michael W. Pill, PharmDJune 24th 2010
Recommendations for the Selection, Treatment, and Management of Patients Utilizing Natalizumab Therapy for Multiple SclerosisByJohn Foley, MDJune 24th 2010
